Michael Pearson, Valeant’s Outgoing CEO Admits Dramatic Increases of Certain Drugs was a Mistake

valeant pharmaceuticals international inc.jpg

On Wednesday, Valeant Pharmaceuticals International Inc's outgoing CEO Mr. Pearson told a Senate committee that the company was too aggressive in radically raising its drug prices and it was a mistake. The company's new CEO and the board members promise that a change will be noticed soon.

read more